Zoi Capital | Digital Health – AI in Healthcare – Venture Capital
Healthcare, Wellness for the Family & Capturing High Investment Returns
Moderated by Tony Forstmann, Chief Investment Officer, Forstmann Asset Management
▪ Ann Oleson, Founder & Partner, Return on Good
▪ Dr. Daniel Baker, Executive Director, Lenox Hill Hospital
▪ Dr. Ronald Razmi, Co-Founder & Managing Director, Zoi
▪ Justin Reinsberg, Senior Vice President, Sollis Health
I recently attended a conference on AI in healthcare, like so many taking place across the country. The room was electric. Slide after slide promised a revolution: flawless predictions, fewer mistakes, faster diagnoses. Some speakers even floated the idea that,
In my most recent article in Fast Company, I discuss the issue that seems to be a major topic of discussion across traditional and social media: Are we in an AI bubble? As I examine in this article, while there are many hallmarks
For anyone that has dealt with the US healthcare system in any way imaginable, there’s mounting frustration. For those of us who have sought care for various issues, we know that barriers and confusion await you at almost every turn:
Keeping up with the theme of the first post of 2026 (US Healthcare Enters 2026 With A High Degree of Uncertainty!), in this recently published article in Fast Company, I discuss some of the foundational problems with the US health economy and why it
Zoi team specializes in driving the adoption of technologies that usher in a new era of better health and healthcare
